People 18 to 59 who are at increased risk of RSV

來源: 於 2024-12-10 21:06:17 [博客] [舊帖] [給我悄悄話] 本文已被閱讀：次
The FDA has approved three vaccines to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults: 
 
  • Abrysvo: Pfizer's vaccine is approved for people 60 and older, and people 18 to 59 who are at increased risk of RSV. It can also be given to pregnant people at 32 to 36 weeks of gestation to prevent LRTD in infants up to 6 months old.
  • Arexvy: GSK's vaccine is approved for people 60 and older, and people 50 to 59 who are at increased risk of RSV.
  • mResvia: Moderna's vaccine is approved for people 60 and older.